Literature DB >> 2039290

Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients.

F B Gelder1, J C McDonald, M D Landreneau, R M McMillan, D F Aultman.   

Abstract

Human lymphocyte antigen (HLA) class I and class II antigens and beta 2 microglobulin (B2M) were identified in peritoneal dialysate (PD) and serum from patients with end-stage renal disease (ESRD) using monoclonal antibodies in an enzyme-linked immunoassay. The HLA class I and class II antigens each exhibited approximate molecular weights of 50,000 to 60,000 daltons by chromatography on Sepharose CL 6B. Class I antigens in serum and PD fluid were associated with B2M. Free B2M (Mr 11,500) also was detected in both sera and PD fluids. Unlike class I antigens, class II antigens were not found to have attached B2M. Class I and class II antigens eluted from 2-diethylaminoethanol ion exchange gradient columns at 0.07 mol/L (molar) phosphate buffer pH 7.2 and migrated with alpha 2-beta 1 mobility in agarose electrophoresis. Class I antigens were purified from ESRD patients' PD fluid by solid-phase immunoaffinity chromatography. Enzyme-linked immunoassay demonstrated that this purified protein was composed of a class I heavy chain and B2M. Class I allospecificity was confirmed by neutralization on known HLA typing antisera in a microcytotoxicity assay. Soluble HLA class I antigen preparations specifically inhibited blast transformation of responder lymphocytes in mixed lymphocyte culture reactions. Inhibition was dose dependent and ranged from 0% to 95%. The presence of soluble HLA antigens in body fluids may play an important part in the immunologic tolerance to self. This study demonstrates a ready source of large quantities of soluble HLA for detailed analysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039290      PMCID: PMC1358583          DOI: 10.1097/00000658-199106000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Peroperative appearance of serum class I antigen during liver transplantation.

Authors:  S G Pollard; H F Davies; R Y Calne
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

2.  Anti HL-A2 inhibitor in normal human serum.

Authors:  J J van Rood; A van Leeuwen; M C van Santen
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

3.  Antibodies against monomorphic determinants of the alpha chain of class I human leukocyte antigens inhibit the reaction of human lymphocytes to mitogen and tetanus toxoid.

Authors:  V R Bonagura; D R Nordli; B Pernis
Journal:  Immunol Invest       Date:  1985-06       Impact factor: 3.657

4.  Specific suppression of human liver recipients' blastogenic response to donor cells by autologous serum.

Authors:  J C McDonald; M D Landreneau; M S Rohr; F B Gelder
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

5.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

6.  Purification, partial characterization, and clinical evaluation of an adenocarcinoma-associated antigen.

Authors:  V B Pinto; F B Gelder; D M Morris
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

7.  Biochemical complexity of serum HLA class I molecules.

Authors:  L M Dobbe; N J Stam; J J Neefjes; M J Giphart
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance.

Authors:  D W King; E Reed; N Suciu-Foca
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

9.  Antigen-specific immunosuppression induced by liver transplantation in the rat.

Authors:  N Kamada; D G Wight
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

10.  Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway.

Authors:  M S Krangel
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Authors:  Irena Adamashvili; Roger E Kelley; Thomas Pressly; John C McDonald
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

Review 2.  In search of the Holy Grail (actively acquired immunologic tolerance).

Authors:  J C McDonald
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

3.  Soluble HLA class I in the serum of transplant recipients.

Authors:  V K Rhynes; J C McDonald; F B Gelder; D F Aultman; J M Hayes; R W McMillan; M C Mancini
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

4.  Peptides derived from a soluble molecule of the human leukocyte antigen (HLA) class I cause apoptosis in gastric cancer cell lines.

Authors:  Tatsuo Shimura; Taketoshi Suehiro; Hideki Suzuki; Yasushi Mochida; Koji Okada; Erito Mochiki; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2008-05-15       Impact factor: 3.199

5.  Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.

Authors:  Irena Adamashvili; Alireza Minagar; Eduardo Gonzalez-Toledo; Liubov Featherston; Roger E Kelley
Journal:  J Neuroinflammation       Date:  2005-06-02       Impact factor: 8.322

6.  Serum and urine soluble HLA class I antigen concentrations are increased in patients with hemorrhagic fever with renal syndrome.

Authors:  C W Park; S N Yun; C W Yang; T G Kim; H Han; E J Choi; Y S Chang; B K Bang
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.